95 related articles for article (PubMed ID: 8221113)
1. L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection.
Weihmuller FB; O'Dell SJ; Marshall JF
Brain Res; 1993 Oct; 623(2):303-7. PubMed ID: 8221113
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
O'Dell SJ; Weihmuller FB; Marshall JF
J Neurochem; 1993 May; 60(5):1792-9. PubMed ID: 8473897
[TBL] [Abstract][Full Text] [Related]
3. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
Weihmuller FB; O'Dell SJ; Marshall JF
Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
[TBL] [Abstract][Full Text] [Related]
4. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.
O'Dell SJ; Weihmuller FB; Marshall JF
Brain Res; 1991 Nov; 564(2):256-60. PubMed ID: 1810626
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity.
Marshall JF; O'Dell SJ; Weihmuller FB
J Neural Transm Gen Sect; 1993; 91(2-3):241-54. PubMed ID: 8099799
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury.
Eisch AJ; Marshall JF
Synapse; 1998 Dec; 30(4):433-45. PubMed ID: 9826235
[TBL] [Abstract][Full Text] [Related]
7. Excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions.
O'Dell SJ; Weihmuller FB; McPherson RJ; Marshall JF
J Pharmacol Exp Ther; 1994 Jun; 269(3):1319-25. PubMed ID: 7912281
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.
Cass WA; Harned ME; Peters LE; Nath A; Maragos WF
Brain Res; 2003 Sep; 984(1-2):133-42. PubMed ID: 12932847
[TBL] [Abstract][Full Text] [Related]
9. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Schmidt CJ; Black CK; Taylor VL
Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
[TBL] [Abstract][Full Text] [Related]
10. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
Hefti F; Melamed E
Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
[TBL] [Abstract][Full Text] [Related]
11. MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study.
Weihmuller FB; O'Dell SJ; Cole BN; Marshall JF
Brain Res; 1991 May; 549(2):230-5. PubMed ID: 1884217
[TBL] [Abstract][Full Text] [Related]
12. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
Jackson D; Abercrombie ED; Zigmond MJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
Wang Y; Perng SL; Lin JC; Tsao WL
Exp Neurol; 1994 Dec; 130(2):279-87. PubMed ID: 7867757
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum.
Nakayama M; Koyama T; Yamashita I
Brain Res; 1993 Jan; 601(1-2):209-12. PubMed ID: 8431767
[TBL] [Abstract][Full Text] [Related]
15. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
GoĊembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
16. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
Abercrombie ED; Bonatz AE; Zigmond MJ
Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
[TBL] [Abstract][Full Text] [Related]
17. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
Cass WA; Walker DJ; Manning MW
Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
[TBL] [Abstract][Full Text] [Related]
18. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
19. Microdialysis studies of D-amphetamine-evoked striatal dopamine overflow in young versus aged F344 rats: effects of concentration and order of administration.
Purdom MS; Stanford JA; Currier TD; Gerhardt GA
Brain Res; 2003 Jul; 979(1-2):203-9. PubMed ID: 12850587
[TBL] [Abstract][Full Text] [Related]
20. Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice.
Naudin B; Bonnet JJ; Costentin J
Brain Res; 1995 Dec; 701(1-2):151-7. PubMed ID: 8925278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
